Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What is the Projected CAGR for the Companion Diagnostics Market Size from 2025 to 2034?
The market size for companion diagnostics has experienced phenomenal growth in the past years. The market which stood at $7.34 billion in 2024, is expected to reach $8.69 billion in 2025, showing an impressive compound annual growth rate (CAGR) of 18.4%. The escalated growth during the historic period is linked to the rise in personalized medicine uptake, advancement of oncology and cancer therapies, increased collaborations of pharmaceutical R&D, precision medicine efforts, and the discovery of biomarkers.
The market size for companion diagnostics is on the brink of tremendous expansion in the approaching years, with projections estimating its value to reach $18.78 billion by 2029 at a compound annual growth rate (CAGR) of 21.2%. Multiple factors contributing to the forecast period’s growth include the development of targeted therapy, diagnostics for infectious and rare diseases, the rise in biomarker-related drug development, point-of-care testing, and the utilization of liquid biopsy applications. Notable market trends predicted in this period encompass advancements in immunotherapy and immunology, the integration of artificial intelligence and machine learning in diagnostics, innovative product introductions, the embracement of industry 4.0, and strategic partnerships.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7038&type=smp
What Are the Primary Drivers Supporting the Market Growth of the Companion Diagnostics Market?
The rise in the number of targeted treatments is predicted to catalyze the expansion of the companion diagnostics market. Focused therapy is a medical treatment that specifically identifies particular features of cancer cells to prevent their proliferation and disease dispersion. These drugs travel throughout the body, but their effect is more concentrated than that of chemotherapy, often resulting in fewer side effects. Performing diagnostic testing based on biological markers for targeted cancer treatment is increasingly becoming a critical component of individualized cancer treatment. For example, in February 2024, the Personalised Medicine Coalition, a hospital and healthcare organization based in the US, reported that the FDA approved 16 novel personalized treatments for patients with rare diseases in 2023, an increase from six in the prior year. Consequently, the escalating number of focused therapies promotes the growth of the companion diagnostics market.
Which Primary Segments of the Companion Diagnostics Market Are Driving Growth and Industry Transformations?
The companion diagnosticsmarket covered in this report is segmented –
1) By Product And Service: Assays, Kits And Reagents, Software And Services
2) By Technology: Polymerase Chain Reaction, Next-Generation Sequencing, In Situ Hybridization, Immunohistochemistry
3) By Indication: Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Melanoma
4) By End-User: Pharmaceutical And Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations
Subsegments:
1) By Assays: Polymerase Chain Reaction (PCR) Assays, Immunohistochemistry (IHC) Assays, Next-Generation Sequencing (NGS) Assays, In Situ Hybridization (ISH) Assays
2) By Kits And Reagents: Diagnostic Kits, Detection Reagents, Control Reagents
3) By Software And Services: Data Analysis Software, Interpretation Software, Custom Development Services, Consulting and Support Services
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=7038&type=smp
Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Companion Diagnostics Market?# Market?
North America was the largest region in the companion diagnostics market in 2024. The regions covered in the companion diagnostics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Are the Most Significant Market Trends in the Companion Diagnostics Market?
The progression of technology is a significant trend within the companion diagnostics sector. The use of artificial intelligence is becoming prevalent in the creation of more efficient pharmaceuticals for companion diagnostic purposes. The consistent accumulation of large data groups from varied genetic profiling is facilitating the extensive usage of AI. Deep Genomics, a business situated in Toronto, applies artificial intelligence to identify improved treatments for genetic conditions and expedite their acceptance for clinical testing. The aim is to use advanced machine learning to delve into the human genome for insights into disease causation, and then formulate and experiment with compounds that may serve as treatments. Deep learning allows academics to experiment with billions of chemical compounds in a virtual model, with the goal of discovering promising formulations to be developed into life-saving remedies for a global population.
View the full report here:
https://www.thebusinessresearchcompany.com/report/companion-diagnostics-global-market-report
What Parameters Are Used to Define the Companion Diagnostics Market?
Companion diagnostics is an in vitro diagnostic medical test used to check the safety and effectivity of a corresponding drug or biological product. The test aids a medical expert to match a patient to a specific drug or therapy.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7038
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model